[Treatment of scabies].
D001593:Benzyl Compounds / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D003437:Crotonates / Q000627:therapeutic use*; D003634:DDT / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use; D001556:Hexachlorocyclohexane / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology; D012532:Scabies / Q000150:complications / Q000188:drug therapy* / Q000469:parasitology; D013587:Syphilis / Q000150:complications; D013827:Thiabendazole / Q000627:therapeutic use*
D001593:Benzyl Compounds; D002087:Butyrates; D003437:Crotonates; D003879:Dermatologic Agents; D001556:Hexachlorocyclohexane; D003634:DDT; D013827:Thiabendazole
Traitement de la gale